PACIFIC BIO CA (P09 BE) stock market data APIs
€1.495
0(0%)
as of November 13, 2025
Try our APIs with
free plan!
PACIFIC BIO CA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for P09.BE.
Prev. Close
1.495
Open
1.495
High
1.495
Low
1.495
52 wk Range
0.7964-2.1635
Market Cap
4 079 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PACIFIC BIO CA data using free add-ons & libraries
Get PACIFIC BIO CA Fundamental Data
PACIFIC BIO CA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PACIFIC BIO CA News
New
How the Narrative Around PacBio Is Shifting After Recent Institutional Moves and Margin Improvements
Pacific Biosciences of California has recently seen its consensus analyst price target edge upward from $2.11 to $2.23 per share, reflecting a modest shift in investor expectations. This change comes ...
Why PacBio (PACB) Shares Are Getting Obliterated Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 7.5% in the afternoon session after the market continued to react negatively to the company's third-quar...
Stocks making big moves yesterday: Bumble, Five Below, PacBio, ON24, and Yum China
Check out the companies making headlines yesterday: Bumble (NASDAQ:BMBL): Online dating app Bumble (NASDAQ:BMBL) fell by 2.3% on Tuesday after a UBS analyst lowered the price target on the stock to $...
5 Revealing Analyst Questions From PacBio’s Q3 Earnings Call
PacBio’s third quarter was met with a significant negative market reaction, reflecting disappointment over revenue that fell short of Wall Street expectations. Management attributed the underperform...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
